Insider Trading Alert - HPJ, BDSI And MOH Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 12, 2014, 103 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $33.00 to $9,071,220.00.

Highlighted Stocks Traded by Insiders:

Highpower International (HPJ) - FREE Research Report

Fisher Truman Joseph III, who is Director at Highpower International, sold 9,000 shares at $5.09 on Dec. 12, 2014. Following this transaction, the Director owned 21,000 shares meaning that the stake was reduced by 30% with the 9,000-share transaction.

The shares most recently traded at $5.01, down $0.08, or 1.52% since the insider transaction. Historical insider transactions for Highpower International go as follows:

  • 4-Week # shares bought: 21,800
  • 4-Week # shares sold: 132,030
  • 12-Week # shares bought: 21,800
  • 12-Week # shares sold: 132,030
  • 24-Week # shares bought: 21,800
  • 24-Week # shares sold: 132,030

The average volume for Highpower International has been 388,500 shares per day over the past 30 days. Highpower International has a market cap of $79.9 million and is part of the industrial goods sector and industrial industry. Shares are up 97.66% year-to-date as of the close of trading on Thursday.

Highpower International, Inc. manufactures and trades nickel metal hydride rechargeable batteries for portable electronic devices. The company has a P/E ratio of 37.9. Currently, there is 1 analyst who rates Highpower International a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HPJ - FREE

TheStreet Quant Ratings rates Highpower International as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins. Get the full Highpower International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BioDelivery Sciences International (BDSI) - FREE Research Report

Sears Samuel P Jr, who is Director at BioDelivery Sciences International, sold 7,853 shares at $15.03 on Dec. 12, 2014. Following this transaction, the Director owned 27,000 shares meaning that the stake was reduced by 22.53% with the 7,853-share transaction.

The shares most recently traded at $13.82, down $1.21, or 8.76% since the insider transaction. Historical insider transactions for BioDelivery Sciences International go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 89,386
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 89,386
  • 24-Week # shares bought: 3,800
  • 24-Week # shares sold: 89,386

The average volume for BioDelivery Sciences International has been 847,800 shares per day over the past 30 days. BioDelivery Sciences International has a market cap of $743.1 million and is part of the health care sector and drugs industry. Shares are up 146.01% year-to-date as of the close of trading on Thursday.

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, develops and commercializes therapeutics in the areas of pain management and oncology supportive care. Currently, there are 4 analysts who rate BioDelivery Sciences International a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on BDSI - FREE

TheStreet Quant Ratings rates BioDelivery Sciences International as a sell. Among the areas we feel are negative, one of the most important has been generally deteriorating net income. Get the full BioDelivery Sciences International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Molina Healthcare (MOH) - FREE Research Report

White Joseph W Cpa, who is Chief Accounting Officer at Molina Healthcare, sold 5,851 shares at $50.80 on Dec. 12, 2014. Following this transaction, the Chief Accounting Officer owned 84,517 shares meaning that the stake was reduced by 6.47% with the 5,851-share transaction.

The shares most recently traded at $51.26, up $0.46, or 0.9% since the insider transaction. Historical insider transactions for Molina Healthcare go as follows:

  • 4-Week # shares sold: 2,719
  • 12-Week # shares sold: 107,233
  • 24-Week # shares sold: 107,233

The average volume for Molina Healthcare has been 661,500 shares per day over the past 30 days. Molina Healthcare has a market cap of $2.4 billion and is part of the health care sector and health services industry. Shares are up 46.39% year-to-date as of the close of trading on Thursday.

Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program. The company operates through two segments, Health Plans and Molina Medicaid Solutions. The company has a P/E ratio of 122.0. Currently, there are 5 analysts who rate Molina Healthcare a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MOH - FREE

TheStreet Quant Ratings rates Molina Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Molina Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers